Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
2012626 citationsUsha Chakravarthy, Simon Harding et al.profile →
Convolutional Neural Networks for Diabetic Retinopathy
2016579 citationsHarry Pratt, Frans Coenen et al.profile →
Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial
2013575 citationsUsha Chakravarthy, Simon Harding et al.The Lancetprofile →
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study)
2010566 citationsFrancesco Bandello, Simon Harding et al.profile →
Automated Vessel Segmentation Using Infinite Perimeter Active Contour Model with Hybrid Region Information with Application to Retinal Images
2015310 citationsSimon Harding, Yalin Zheng et al.profile →
Defining response to anti-VEGF therapies in neovascular AMD
2015262 citationsWinfried M. K. Amoaku, Usha Chakravarthy et al.Eyeprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Simon Harding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Harding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Harding more than expected).
This network shows the impact of papers produced by Simon Harding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Harding. The network helps show where Simon Harding may publish in the future.
Co-authorship network of co-authors of Simon Harding
This figure shows the co-authorship network connecting the top 25 collaborators of Simon Harding.
A scholar is included among the top collaborators of Simon Harding based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Simon Harding. Simon Harding is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Harding, Simon. (2020). County Lines. Bristol University Press eBooks.1 indexed citations
6.
Pratt, Harry, et al.. (2019). Feature visualisation of classification of diabetic retinopathy using a convolutional neural network. International Joint Conference on Artificial Intelligence. 23–29.2 indexed citations
Sheth, Viral, Chatonda Manda, Frank A. Proudlock, et al.. (2018). Hand-held Optical Coherence Tomography – A New Biomarker of Brain Swelling in Cerebral Malaria. Investigative Ophthalmology & Visual Science. 59(9). 612–612.1 indexed citations
Zheng, Yalin, et al.. (2015). Impact of hypertension on choroidal thickness in central serous chorioretinopathy. Investigative Ophthalmology & Visual Science. 56(7). 3717–3717.1 indexed citations
12.
Amoaku, Winfried M. K., Usha Chakravarthy, Richard Gale, et al.. (2015). Defining response to anti-VEGF therapies in neovascular AMD. Eye. 29(6). 721–731.262 indexed citations breakdown →
13.
Czanner, Gabriela, Simon Harding, M Holland, et al.. (2015). Safety and acceptability of an organic light emitting diode (OLED) sleep mask for the treatment of retinal diseases: INSIGHT Study. Investigative Ophthalmology & Visual Science. 56(7). 3161–3161.
14.
Scott, Lauren J, Usha Chakravarthy, Susan M. Downes, et al.. (2014). Gastrointestinal serious adverse events in patients treated with intraocular ranibizumab or bevacizumab for age-related choroidal neovascularisation, what do the recent trials tell us?. Investigative Ophthalmology & Visual Science. 55(13). 1648–1648.2 indexed citations
15.
Leitner, Jürgen, et al.. (2013). ALife in humanoids: Developing a framework to employ artificial life techniques for high-level perception and cognition tasks on humanoid robots. QUT ePrints (Queensland University of Technology).1 indexed citations
Harding, Simon, et al.. (1989). Metabolism Tabulated: A Hypermedia Template for Drill and Review of Tabular Information. PubMed Central. 1035–1036.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.